GFC Life Sciences Participates in ‘In-Cosmetics Global 2025’

GFC Life Science (GFC, Co-CEOs Kang Hee-chul and Pyo Hyeong-bae), a plant cell-based biomaterials company, announced on the 11th that it participated in 'In-cosmetics Global 2025' held in Amsterdam, the Netherlands for three days from the 8th to the 10th (local time) and showcased various biomaterials that embody the company's technological prowess.

'In-Cosmetics Global' is an international cosmetic raw material exhibition with the participation of cosmetic raw material manufacturers, suppliers, and R&D personnel from over 280 countries. GFC Life Science exhibited its main cosmetic bio-materials: ▲Milk-Exo ▲Camellia Stem-Exo ▲Plant-based PDRN (Poly Deoxy Ribo Nucleotide) ▲Bio-Gold ginseng ▲Realtox ▲Kera.B, etc.

The company also said that it had conducted an oral presentation (technical seminar) on the 'Skin Improvement Effects of Plant Exosome-Derived MiRNA (MicroRNA)' and received favorable reviews from various global buyers including those from the US, France, Spain, Poland, and Ukraine.

Plant miRNAs are small RNA molecules that function to regulate various development and physiology of plants. It is known that the exosomal miRNA expression patterns are different for each plant, and the skin improvement effects that can be obtained are also different for each plant.

GFC Life Science has developed the ‘Plant Exosome Biobarcode-miRNA System’, an exosome verification technology that utilizes the specific expression pattern of miRNA present in plant exosomes through many years of research, and unveiled it for the first time at this exhibition. The company plans to commercialize the 4th generation Skin Booster product with this technology applied as early as the second half of this year.

Kang Hee-chul, CEO of GFC Life Science, said, “We have proven our differentiated technological prowess through an oral presentation of ‘plant miRNA’ at in-cosmetics Global, the world’s largest cosmetics raw material exhibition,” and expressed his aspiration, “As vegan cosmetics that exclude animal-derived raw materials have become a global trend, we will continue to discover biomaterials based on our unrivaled exosome technology and lead the global market.”

Meanwhile, GFC Life Science, established in 2002, is a bio-linked beauty tech company that has developed over 2,000 types of bio-cosmetic materials and is supplying them to domestic and international cosmetics ODM (Original Design Manufacturer), OEM (Original Equipment Manufacturer) and brand manufacturers. The company, which is currently pursuing a KOSDAQ listing, passed the preliminary screening for listing on KOSDAQ on the 4th of this month and plans to file a securities report and begin full-scale initial public offering (IPO) procedures.


  • See more related articles